FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2122474968> ?p ?o ?g. }

• W2122474968 endingPage "2105" @default.
• W2122474968 startingPage "2098" @default.
• W2122474968 abstract "ABSTRACT We describe the pharmacokinetics (PKs) of caspofungin, an echinocandin antifungal, administered once daily as a 1-hour intravenous infusion in children and adolescents (ages, 3 months to 17 years), based on pooled data from four prospective pediatric studies. Caspofungin dosing was body-surface-area (BSA) based (50 mg/m 2 daily after 70 mg/m 2 on day 1). The area under the concentration-time curve from time zero to 24 h (AUC 0–24 ), the concentration at the end of infusion (1 h after the start of infusion; C 1 ), and the trough concentration (24 h after the start of infusion; C 24 ) were obtained for 32 pediatric patients with invasive candidiasis, 10 with invasive aspergillosis, and 82 in the setting of empirical therapy with fever and neutropenia. Exposures were modestly higher (93 to 134% for C 1 , 45 to 78% for C 24 , ∼40% for AUC 0–24 ) in pediatric patients than in adults receiving the standard 50-mg daily dose. The potential for covariates (age, gender, weight, race, renal status, serum albumin level, and disease state) to alter PKs was evaluated with a multiple-linear-regression model. Weight and disease state had statistically significant ( P < 0.05) yet small effects on caspofungin PKs in pediatric patients. Concomitant use of dexamethasone (a cytochrome p450 inducer) was associated with a statistically significant reduction (44%) in C 24 in a limited number of patients ( n = 4). Odds ratios were estimated for the association between log-transformed PKs and treatment outcome or adverse events. No PK parameter or hybrid parameter (AUC/MIC, C 1 /MIC, and C 24 /MIC) was significantly correlated with treatment outcome or adverse events in the setting of similar response levels as adults, which suggests that the concentrations examined fall within the therapeutic window for caspofungin in pediatric patients. These results support a 50-mg/m 2 daily dosing regimen (after a 70-mg/m 2 loading dose) in children ages 3 months to 17 years." @default.
• W2122474968 created "2016-06-24" @default.
• W2122474968 creator A5005368643 @default.
• W2122474968 creator A5011351249 @default.
• W2122474968 creator A5019544224 @default.
• W2122474968 creator A5022506632 @default.
• W2122474968 creator A5024807342 @default.
• W2122474968 creator A5034116722 @default.
• W2122474968 creator A5039187516 @default.
• W2122474968 creator A5077299912 @default.
• W2122474968 creator A5079085433 @default.
• W2122474968 creator A5089004534 @default.
• W2122474968 date "2011-05-01" @default.
• W2122474968 modified "2023-10-16" @default.
• W2122474968 title "Population Pharmacokinetics and Pharmacodynamics of Caspofungin in Pediatric Patients" @default.
• W2122474968 cites W1972127359 @default.
• W2122474968 cites W1974440562 @default.
• W2122474968 cites W1979274559 @default.
• W2122474968 cites W1991891947 @default.
• W2122474968 cites W1992440113 @default.
• W2122474968 cites W1994259218 @default.
• W2122474968 cites W2003661565 @default.
• W2122474968 cites W2006277360 @default.
• W2122474968 cites W2024310762 @default.
• W2122474968 cites W2041457471 @default.
• W2122474968 cites W2068319549 @default.
• W2122474968 cites W2077408731 @default.
• W2122474968 cites W2097394217 @default.
• W2122474968 cites W2099769947 @default.
• W2122474968 cites W2105380497 @default.
• W2122474968 cites W2112230834 @default.
• W2122474968 cites W2114146849 @default.
• W2122474968 cites W2138348369 @default.
• W2122474968 cites W2142281465 @default.
• W2122474968 cites W2142482664 @default.
• W2122474968 cites W2146558016 @default.
• W2122474968 cites W2151085150 @default.
• W2122474968 cites W2154056008 @default.
• W2122474968 cites W2156228013 @default.
• W2122474968 cites W2162221318 @default.
• W2122474968 cites W2164615015 @default.
• W2122474968 cites W2168334830 @default.
• W2122474968 cites W2171824055 @default.
• W2122474968 doi "https://doi.org/10.1128/aac.00905-10" @default.
• W2122474968 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3088186" @default.
• W2122474968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21300834" @default.
• W2122474968 hasPublicationYear "2011" @default.
• W2122474968 type Work @default.
• W2122474968 sameAs 2122474968 @default.
• W2122474968 citedByCount "33" @default.
• W2122474968 countsByYear W21224749682012 @default.
• W2122474968 countsByYear W21224749682013 @default.
• W2122474968 countsByYear W21224749682014 @default.
• W2122474968 countsByYear W21224749682015 @default.
• W2122474968 countsByYear W21224749682016 @default.
• W2122474968 countsByYear W21224749682017 @default.
• W2122474968 countsByYear W21224749682018 @default.
• W2122474968 countsByYear W21224749682019 @default.
• W2122474968 countsByYear W21224749682020 @default.
• W2122474968 countsByYear W21224749682021 @default.
• W2122474968 countsByYear W21224749682022 @default.
• W2122474968 crossrefType "journal-article" @default.
• W2122474968 hasAuthorship W2122474968A5005368643 @default.
• W2122474968 hasAuthorship W2122474968A5011351249 @default.
• W2122474968 hasAuthorship W2122474968A5019544224 @default.
• W2122474968 hasAuthorship W2122474968A5022506632 @default.
• W2122474968 hasAuthorship W2122474968A5024807342 @default.
• W2122474968 hasAuthorship W2122474968A5034116722 @default.
• W2122474968 hasAuthorship W2122474968A5039187516 @default.
• W2122474968 hasAuthorship W2122474968A5077299912 @default.
• W2122474968 hasAuthorship W2122474968A5079085433 @default.
• W2122474968 hasAuthorship W2122474968A5089004534 @default.
• W2122474968 hasBestOaLocation W21224749682 @default.
• W2122474968 hasConcept C111113717 @default.
• W2122474968 hasConcept C112705442 @default.
• W2122474968 hasConcept C126322002 @default.
• W2122474968 hasConcept C16005928 @default.
• W2122474968 hasConcept C2776694085 @default.
• W2122474968 hasConcept C2777063308 @default.
• W2122474968 hasConcept C2777288759 @default.
• W2122474968 hasConcept C2777501473 @default.
• W2122474968 hasConcept C2779320740 @default.
• W2122474968 hasConcept C2779384505 @default.
• W2122474968 hasConcept C2779548794 @default.
• W2122474968 hasConcept C2780402444 @default.
• W2122474968 hasConcept C2780651595 @default.
• W2122474968 hasConcept C2908647359 @default.
• W2122474968 hasConcept C71924100 @default.
• W2122474968 hasConcept C76318530 @default.
• W2122474968 hasConcept C98274493 @default.
• W2122474968 hasConcept C99454951 @default.
• W2122474968 hasConceptScore W2122474968C111113717 @default.
• W2122474968 hasConceptScore W2122474968C112705442 @default.
• W2122474968 hasConceptScore W2122474968C126322002 @default.
• W2122474968 hasConceptScore W2122474968C16005928 @default.
• W2122474968 hasConceptScore W2122474968C2776694085 @default.
• W2122474968 hasConceptScore W2122474968C2777063308 @default.
• W2122474968 hasConceptScore W2122474968C2777288759 @default.

• next